sq 28603 has been researched along with Heart Failure in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abboa-Offei, BE; Asaad, MM; Mathers, PD; Rogers, WL; Seymour, AA; Smith, PL | 1 |
| Abassi, ZA; Golomb, E; Keiser, HR; Kotob, S; Pieruzzi, F | 1 |
| Fox, M; Panchal, BC; Trippodo, NC | 1 |
| Asaad, MM; Cheung, HS; Fennell, SA; Lanoce, VM; Rogers, WL; Seymour, AA | 1 |
| Asaad, MM; Fennell, SA; Langenbacher, KM; Lanoce, VM; Rogers, WL; Seymour, AA | 1 |
| Dietz, R; Höhnel, K; Luft, FC; Scheuermann, M; Willenbrock, R | 1 |
| Burnett, JC; Margulies, KB; McKinley, LJ; Perrella, MA | 1 |
| Asaad, MM; Gabel, RA; Harvey, CM; Rogers, WL; Trippodo, NC | 1 |
1 review(s) available for sq 28603 and Heart Failure
| Article | Year |
|---|---|
Potentiation of natriuretic peptides by neutral endopeptidase inhibitors.
Topics: Alanine; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Heart Failure; Hemodynamics; Hypertension; Neprilysin | 1995 |
7 other study(ies) available for sq 28603 and Heart Failure
| Article | Year |
|---|---|
Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure.
Topics: Alanine; Animals; Base Sequence; Heart Failure; Kidney; Lung; Male; Molecular Sequence Data; Neprilysin; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1995 |
Repression of angiotensin II and potentiation of bradykinin contribute to the synergistic effects of dual metalloprotease inhibition in heart failure.
Topics: Alanine; Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Blood Volume; Bradykinin; Cricetinae; Drug Synergism; Enalaprilat; Heart Failure; Irbesartan; Male; Neprilysin; Tetrazoles; Vasodilation; Ventricular Function, Left | 1995 |
Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure.
Topics: Alanine; Animals; Atrial Natriuretic Factor; Cardiac Pacing, Artificial; Cyclic GMP; Dogs; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Kidney; Male; Natriuresis; Neprilysin; Protease Inhibitors; Urine | 1993 |
Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Captopril; Cardiac Pacing, Artificial; Cyclic GMP; Dogs; Female; Heart Failure; Hemodynamics; Kidney; Male; Neprilysin; Renin | 1993 |
Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
Topics: Alanine; Angiotensin II; Animals; Aorta, Abdominal; Arteriovenous Shunt, Surgical; Atrial Natriuretic Factor; Cyclic GMP; Diuresis; Enzyme Inhibitors; Heart Failure; Hemodynamics; Male; Natriuresis; Neprilysin; Rats; Rats, Wistar; Renin; Vena Cava, Inferior | 1996 |
Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.
Topics: Alanine; Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Dogs; Heart Failure; Hemodynamics; Kidney; Male; Neprilysin; Sodium | 1991 |
Heart failure augments the cardiovascular and renal effects of neutral endopeptidase inhibition in rats.
Topics: Alanine; Animals; Blood Pressure; Body Weight; Central Venous Pressure; Heart Failure; Heart Rate; Hemodynamics; Kidney; Male; Myocardial Infarction; Neprilysin; Protease Inhibitors; Rats; Rats, Inbred Strains | 1991 |